Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas…
BIG FM is Now India's Largest Radio Network with 67 Stations Across the Country
BIG FM, now India’s largest radio network, has strengthened its presence by…
Florricks Lifecare Expands Global Footprint with USD 95 Million Investment in Europe and Hong Kong
Florricks Lifecare Private Limited, a leading research-driven global pharmaceutical company renowned for…
ServiceTrade Launches Grow Your Own Technician Workforce Program with VSC Fire & Security and Durham Tech
$5,000 grant will underwrite a new apprentice hire and training; the program…
Manipal Hospital Sarjapur Road Empowers Fitness Enthusiasts with CPR Skills and First-Aid Workshop
BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- With the growing emphasis on…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
Mumbai Indians extend Mighty Indians IP with 3D Webisodes and More
Mumbai Indians today announced the launch of Season 2 of Mighty Indians with an…
Netrack Engages Industry Leaders at BICSI Chennai with Future-oriented IT-solutions
Netrack’s participation in the BICSI event in Chennai on December 21st 2024,…
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
SM Yugan from Tamil Nadu, India Created History with Triple Gold at Asian Shooting Championships 2025
Tamil Nadu’s SM Yugan, just 14 years old, scripted history at the…